Abstract：Objective To explore the evidence, urinary biomarkers, and partial mechanisms of hypercoagulability in the pathogenesis of IgA vasculitis (IgAV). Methods Differential expression of proteins in the urine of 10 healthy children and 10 children with IgAV was screened using high-performance liquid chromatography-tandem mass spectrometry, followed by Reactome pathway analysis. Protein-protein interaction (PPI) network analysis was conducted using STRING and Cytoscape software. In the validation cohort, 15 healthy children and 25 children with IgAV were included, and the expression levels of differential urinary proteins were verified using enzyme-linked immunosorbent assay. Results A total of 772 differential proteins were identified between the IgAV group and the control group, with 768 upregulated and 4 downregulated. Reactome pathway enrichment results showed that neutrophil degranulation, platelet activation, and hemostasis pathways were involved in the pathogenesis of IgAV. Among the differential proteins, macrophage migration inhibitory factor (MIF) played a significant role in neutrophil degranulation and hemostasis, while thrombin was a key protein in platelet activation and hemostasis pathways. PPI analysis indicated that thrombin directly interacted with several proteins involved in inflammatory responses, and these interactions involved MIF. Validation results showed that compared to healthy children, children with IgAV had significantly higher urine thrombin/creatinine and urine MIF/creatinine levels (P<0.05). Conclusions Thrombin contributes to the pathogenesis of IgAV through interactions with inflammatory factors. Urinary thrombin and MIF can serve as biomarkers reflecting the hypercoagulable and inflammatory states in children with IgAV.
LIU Meng-Meng,HOU Gai-Ling,YANG Xiao-Qing et al. Exploring the mechanism of IgA vasculitis pathogenesis through the interaction of thrombin and inflammatory factors using urinary proteomics[J]. CJCP, 2024, 26(7): 683-689.
Mayer-Hain S, Gebhardt K, Neufeld M, et al. Systemic activation of neutrophils by immune complexes is critical to IgA vasculitis[J]. J Immunol, 2022, 209(6): 1048-1058. PMID: 35985788. DOI: 10.4049/jimmunol.2100924.
Giardini AC, Evangelista BG, Sant'Anna MB, et al. Crotalphine attenuates pain and neuroinflammation induced by experimental autoimmune encephalomyelitis in mice[J]. Toxins (Basel), 2021, 13(11): 827. PMID: 34822611. PMCID: PMC8624587. DOI: 10.3390/toxins13110827.
Grande MA, Belstr?m D, Damgaard C, et al. Salivary concentrations of macrophage activation-related chemokines are influenced by non-surgical periodontal treatment: a 12-week follow-up study[J]. J Oral Microbiol, 2020, 12(1): 1694383. PMID: 31893018. PMCID: PMC6913660. DOI: 10.1080/20002297.2019.1694383.
Jaszczura M, Mizga?a-Izworska E, ?wi?tochowska E, et al. Serum levels of selected cytokines [interleukin (IL)-17A, IL-18, IL-23] and chemokines (RANTES, IP10) in the acute phase of immunoglobulin A vasculitis in children[J]. Rheumatol Int, 2019, 39(11): 1945-1953. PMID: 31468124. PMCID: PMC7575498. DOI: 10.1007/s00296-019-04415-4.
Witkowski M, Landmesser U, Rauch U. Tissue factor as a link between inflammation and coagulation[J]. Trends Cardiovasc Med, 2016, 26(4): 297-303. PMID: 26877187. DOI: 10.1016/j.tcm.2015.12.001.
Huang W, Zhan D, Li Y, et al. Proteomics provides individualized options of precision medicine for patients with gastric cancer[J]. Sci China Life Sci, 2021, 64(8): 1199-1211. PMID: 34258712. DOI: 10.1007/s11427-021-1966-4.
Jia L, Wu J, Wei J, et al. Proteomic analysis of urine reveals biomarkers for the diagnosis and phenotyping of abdominal-type Henoch-Schonlein purpura[J]. Transl Pediatr, 2021, 10(3): 510-524. PMID: 33850810. PMCID: PMC8039785. DOI: 10.21037/tp-20-317.
Audemard-Verger A, Pillebout E, Guillevin L, et al. IgA vasculitis (Henoch-Sh?nlein purpura) in adults: diagnostic and therapeutic aspects[J]. Autoimmun Rev, 2015, 14(7): 579-585. PMID: 25688001. DOI: 10.1016/j.autrev.2015.02.003.
Dziedzic A, Miller E, Saluk-Bijak J, et al. The molecular aspects of disturbed platelet activation through ADP/P2Y12 pathway in multiple sclerosis[J]. Int J Mol Sci, 2021, 22(12): 6572. PMID: 34207429. PMCID: PMC8234174. DOI: 10.3390/ijms22126572.
Zeng FY, Kratzin H, Gabius HJ. Migration inhibitory factor-binding sarcolectin from human placenta is indistinguishable from a subfraction of human serum albumin[J]. Biol Chem Hoppe Seyler, 1994, 375(6): 393-399. PMID: 7980871. DOI: 10.1515/bchm3.1994.375.6.393.
Luo Y, Yi H, Huang X, et al. Inhibition of macrophage migration inhibitory factor (MIF) as a therapeutic target in bleomycin-induced pulmonary fibrosis rats[J]. Am J Physiol Lung Cell Mol Physiol, 2021, 321(1): L6-L16. PMID: 33881353. DOI: 10.1152/ajplung.00288.2020.
Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease[J]. Nature, 1992, 359(6397): 693-699. PMID: 1436033. PMCID: PMC3889166. DOI: 10.1038/359693a0.
Kulkarni AB, Huh CG, Becker D, et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death[J]. Proc Natl Acad Sci U S A, 1993, 90(2): 770-774. PMID: 8421714. PMCID: PMC45747. DOI: 10.1073/pnas.90.2.770.
Liu L, Liu H, Zhu K, et al. Proteome analysis reveals novel serum biomarkers for Henoch-Sch?nlein purpura in Chinese children[J]. J Proteomics, 2023, 276: 104841. PMID: 36796721. DOI: 10.1016/j.jprot.2023.104841.
Tarasuk M, Poungpair O, Ungsupravate D, et al. Human single-chain variable fragment antibody inhibits macrophage migration inhibitory factor tautomerase activity[J]. Int J Mol Med, 2014, 33(3): 515-522. PMID: 24424397. PMCID: PMC3926510. DOI: 10.3892/ijmm.2014.1622.
Brown FG, Nikolic-Paterson DJ, Hill PA, et al. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis[J]. J Am Soc Nephrol, 2002, 13 (Suppl 1): S7-S13. PMID: 11792756.
